Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10010758HBVENSG00000142168.15protein_codingSOD1NoNo6647P00441
TVIS30054522HIVENSG00000142168.15protein_codingSOD1NoNo6647P00441
TVIS20014277HPVENSG00000142168.15protein_codingSOD1NoNo6647P00441
TCGA Plot Options
Drug Information
GeneSOD1
DrugBank IDDB00988
Drug NameDopamine
Target IDBE0002390
UniProt IDP00441
Regulation Type
PubMed IDs23612299
CitationsWright GS, Antonyuk SV, Kershaw NM, Strange RW, Samar Hasnain S: Ligand binding and aggregation of pathogenic SOD1. Nat Commun. 2013;4:1758. doi: 10.1038/ncomms2750.
GroupsApproved
Direct ClassificationCatecholamines and derivatives
SMILESNCCC1=CC(O)=C(O)C=C1
PathwaysRemifentanil Action Pathway; Hydrocodone Action Pathway; Sufentanil Action Pathway; Morphine Action Pathway; Fluoxetine Action Pathway; 3-Methylthiofentanyl Action Pathway; Benzocaine Action Pathway; Oxybuprocaine Action Pathway; Codeine Action Pathway; Alkaptonuria; Tyrosine Hydroxylase Deficiency; Ketobemidone Action Pathway; Propoxyphene Action Pathway; Dihydromorphine Action Pathway; Nicotine Action Pathway; Proparacaine Action Pathway; Methadyl Acetate Action Pathway; Hawkinsinuria; Oxymorphone Action Pathway; Fentanyl Action Pathway; Dimethylthiambutene Action Pathway; Dopamine beta-Hydroxylase Deficiency; Lidocaine (Local Anaesthetic) Action Pathway; Monoamine Oxidase-A Deficiency (MAO-A); Aromatic L-Aminoacid Decarboxylase Deficiency; Hydromorphone Action Pathway; Tyrosinemia, Transient, of the Newborn; Anileridine Action Pathway; Bupivacaine Action Pathway; Dopamine Activation of Neurological Reward System
PharmGKBPA449396
ChEMBLCHEMBL59